Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Let's not underestimate the Trump factor to push ELTP higher in the coming months leading to the general election. A tax break for a little company such as Elite would do wonders in freeing some extra cash to reinvest in its R & D. I have no doubt that a US president Trump would be in office.
Cheers!
Bend but not break the 30-cents base.
Cheers!
Indeed, the low volume is an indication that investors are not selling in general. We should see volume pickup as we get closer to July. The financial reporting would not hurt, too.
Cheers!
American Pain Society 35th Annual Scientific Meeting
Elite Pharmaceuticals presented data for SequestOx™ (ELI-200) at the American Pain Society 35th Annual Scientific Meeting being held in Austin, Texas, USA, May 11 – 14, 2016. The poster, entitled, Pharmacodynamic data assessing the abuse potential of a novel abuse deterrent oxycodone formulation (ELI-200) compared to oxycodone immediate release, oral intact ELI-200, and placebo in healthy, non-dependent recreational opioid users following intranasal administration, has been posted on the company’s website at: http://ir.elitepharma.com/events_presentations.
Cheers!
In ancient Egypt, there is a custom that when you talk about the dead, they are not dead. Just the living dead. So now, we are here talking about KMAG. The soul of KMAG rests with JR.
Cheers!
I believe in reincarnation.
Cheers!
The tragic controversy regarding the abuse in prescription pain medication has created sufficient attention for potential investors to research the list of ADT drug manufacturers that would have the next BIG THING. Folks, the genie is in a bottle of SequestOx(ELI-200).
Cheers!
I guess an afterlife is true for KMAG.
Cheers!
As for ELTP, consolidation is the mother of all upward trends given growth in its fundamentals. Adding fuel to the fire, the abuse of prescription pain medication is an epidemic, which exploded in an unimaginable scale worldwide, that is cause for alarm. Demand for ADT drugs would be high in demand with the cooperation of the government to legislate policies to push more of these drugs.
Cheers!
Believe in Solos!
Cheers!
Love the math. Elite has a working formula.
Cheers!
Always appreciate the nice close today.
Cheers!
Hakim is mostly action and less talk.
Cheers!
Greed is good! No pork chops if you are late at the dinner table.
Cheers!
Exciting times are coming our way! Stock up on ELTP before our date with the FDA in July.
Cheers!
It is what it is.
Cheers!
Good news! Hakim will speak and take questions in upcoming CC, following the financial report.
Cheers!
Stopping over at Starbuck's for my early morning cup of Joe. Good to add at the support of 30-cents.
Cheers!
Your daily observation of the daily share price contradicts the long-term price/volume charts, which shows the share price higher in reference to 2011. A pending FDA-approval in July has not been priced in the stock, yet.
Cheers!
Time for a end of day run?
Cheers!
Based on today's volume, the savvy investors are not selling. The current PPS has not discouraged buyers looking for bargains.
Cheers!
No regrets. I would be short changed if I were to sell at 97-cents. ELTP is going higher with fewer road blocks ahead.
Cheers!
No, Hakim is keeping his promise to build Elite's fundamentals. Expect to see another record-breaking financials in the future after the ELIs are commercialized. I would be crazy to sell now. This baby is still growing.
Cheers!
The previous surge to 97-cents was due to speculation without substance or basis. Our current non-ADT drug pipeline and our ELI drug line combined is the game changer that would naturally increase the PPS beyond 97-cents.
Cheers!
I look at my portfolio gains of ELTP that others would be green with envy.
Cheers!
Action speaks louder than words. As for Elite, I look at what she has achieved and periodically re-evaluate it's SWOT(strength, weaknesses, opportunities, and threats).
Cheers!
Elite's revenues offers valid, independent analysis.
Cheers!
Lol, Aqua is keeping the PPS at 32-cents to allow her friends to buy undervalued shares.
Cheers!
Hoping for a share buyback with the cash Elite would accumulate from revenues alone.
Cheers!
People just need to go on the Elite Pharma website and look up the list of drugs, both commercialized and potential NDA, to be convinced.
Cheers!
I consider myself a smart investor after buying a majority of my shares under 10-cents, starting at 4-cents when I was in Kyoto, Japan in 2011.
Cheers!
It is methodical process. There are specific protocols and guidelines that drug makers must comply according to FDA standards, codes, and ethics.
Cheers!
ELTP is a sure bet. The ELI drugs would pull in substantial revenues as we move forward. Our peers know this stock would not be a penny stock for too long. ELTP is not your typical OTC company.
Cheers!
One tough pill that is worth more than its weight in gold.
Cheers!
More exciting chapters to come for Elite.
Cheers!
It's 6:39 AM. Just spreading the Aloha to ELTP investors.
Cheers!
Nice volume brewing with the share price set for an upward trend.
Cheers!
I agree. All bets are off for those trying to revive the 2-cents per share theory. The ELI product would be set in motion. This is a no brainer investment.
Cheers!
A list of reasons to invest in ELTP.
Cheers!
Elite's ELI drugs is a step forward.
Cheers!